New program aims to boost HIV med adherence and mental health for MSM in south africa
NCT ID NCT06880172
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study tested a behavioral program called WeCare for men who have sex with men (MSM) in South Africa. The program included individual sessions to identify problems and create action plans, plus group sessions for social support and coping with stigma. The goal was to improve mental health and help participants stick to their HIV medication (ART or PrEP). Only 12 men took part, so the results are very preliminary.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
WeCare behavioral program
What this could lead to
If successful, this program could offer a practical way to support mental health and medication adherence for men who have sex with men living with or at risk for HIV.
What could go wrong
This was a very small pilot study with only 12 participants, so results may not apply to larger groups. The program requires group sessions, which may not work for everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Aurum Institute
Johannesburg, 2194, South Africa